Biotech and Healthcare Stocks Lagging
Healthcare Stocks Lag but Trading Action is Picking up in Biotech Large Cap Biopharma are core holdings: ABBV, LLY, MRK, REGN, VRTX etc. Healthcare is a laggard with XLV down YTD but UNH is still a core position. Lack of Momentum in SMID caps-XBI is still the key indicator. Not much happened...
Macro Muddle Coming Up as Market Exceeds Expectations, Small Caps Gain Ground…Update-2
Update-2 6/18...11 a EDT, Medtech Rally: FSMEX , IHI, ABT, BSX etc. Update-1 2P EDT 6/14...FED day brings volatility and easing of momentum. Don't fight the tape with small caps weak. XBI is down 2%, Russell 2000 is down 1.65%. We started selling and rebalancing stocks in our Life Science...
Market Mixes it Up With a Broad Rally…Update-2 6/7/23
FOCUS on SMID biotech stocks. Update-2 ..more rotation out of tech and large cap biopharma and healthcare (UNH, XLV still weak) into value and cyclicals; energy very strong we'll see. We still prefer SMID in biotech per our Life Science Portfolio. Today XBI was flat at $88 but good gains in EVH...
Rotation Out of Healthcare and Biotech Stocks: Age of Disruption? Update-1 Large Cap Biopharma
Update -1 3/31 2P EDT. With momentum easing in Chip and IT trades this can be a good entry point for large cap biopharma stocks ahead of ASCO June 2: GILD, MRK so stay tuned. Also for value "bottom fishers" Pfizer offers a good yield of 4.4% with a FWD PE about 10 and a strong balance sheet....
A Good Week for the Market but a Pause in the Biotech Rally…Update-2 Got Tech?
Update-2 5/27/23... Not a great week for healthcare stocks or anything other than IT and the QQQ up 3.59%. S&P 500 Healthcare down 2.93%, Materials down 3.14%, Staples down 3.21%. No debt ceiling deal, recession watch is on. So Karen Firestone, former manager of the Fidelity Biotechnology...